Nanobiotix S.A.（NBTX）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · NBTX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$29.64M	($7.19M)	$36.21M	$4.78M	$2.65M
Cost of Revenue	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Gross Profit	$29.64M	($7.19M)	$36.21M	$4.78M	$2.65M
Gross Margin %(computed)	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Expenses
R&D Expenses	$23.11M	$40.54M	$38.40M	$32.64M	$30.38M
G&A Expenses	$20.22M	$0.00M	$0.00M	$0.00M	$0.00M
Total Operating Expenses	$40.46M	$61.20M	$62.99M	$51.48M	$55.23M
Operating Income	($10.82M)	($68.39M)	($26.78M)	($46.70M)	($52.58M)
Operating Margin %(computed)	-36.49%	951.21%	-73.96%	-977.85%	—
Interest Income	$0.98M	$2.63M	$1.22M	$0.26M	$0.00M
Interest Expense	$10.39M	$8.09M	$7.98M	$5.84M	$0.70M
Income Before Tax	($23.96M)	($68.03M)	($39.58M)	($57.03M)	($47.00M)
Income Tax Expense	$0.00M	$0.10M	$0.12M	$0.01M	$0.01M
Net Income	($23.96M)	($68.13M)	($39.70M)	($57.04M)	($47.00M)
Net Margin %(computed)	-80.83%	947.59%	-109.64%	—	—
Per Share & EBITDA
EPS (Basic)	$-0.50	$-1.44	$-1.08	$-1.64	$-1.35
Wtd Avg Shares	47.82M	47.27M	36.76M	34.85M	34.73M
EBITDA	($12.07M)	($67.67M)	($23.69M)	($44.22M)	($45.60M)
EBITDA Margin %(computed)	-40.71%	941.11%	-65.42%	-925.82%	—